FDA Clears Imagyn Device for Marketing
LAGUNA NIGUEL — Imagyn Medical Inc. said Thursday it has received clearance from the Food and Drug Administration to market its MicroSpan sheath, which will permit physicians to diagnose and treat uterine disorders with minimally invasive procedures. Imagyn Medical designs, develops and markets “micro-invasive” device systems for the diagnosis and treatment of gynecological and reproductive disorders.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
